Amgen reports Q1 profit of $1.73 billion, beats expectations, and provides positive outlook for FY25.

From Nasdaq: 2025-05-02 02:05:00

Amgen Inc. reported a profit in the first quarter of 2025, with net income of $1.73 billion or $3.20 per share, compared to a loss last year. The company’s earnings exceeded expectations, driven by higher revenues and an unrealized gain on its BeiGene, Ltd. equity investment. Revenues for the quarter rose 9 percent to $8.15 billion, with a 11 percent growth in product sales. Amgen provided an outlook for fiscal 2025, expecting earnings per share between $12.21 to $13.46 and total revenues between $34.3 billion and $35.7 billion. Analysts predict earnings per share of $20.63 on revenues of $35.12 billion for the year.



Read more at Nasdaq: Amgen Swings To Q1 Profit, Beats Street View; Guides FY25